Bayer's finerenone approved in India for heart failure
FDA approves UCB’s Kygevvi for rare genetic mitochondrial disease TK2 deficiency
J&J MedTech reports strong one-year results for shockwave peripheral IVL system in DISRUPT BTK II trial
Eli Lilly to invest $1.2 billion in Puerto Rico to boost U.S. oral medicine production
RedHill secures final $10.5M court judgment for enforcement
Sumitomo Pharma America unveils promising new leukemia and myelofibrosis data ahead of ASH 2025
Ginkgo Bioworks and Bayer renew partnership to power the next wave of Ag Biologicals
Marksans Pharma’s UK Arm Relonchem secures MHRA nod for Exemestane 25mg Tablets
Cupid bags largest share in South Africa’s 5-year National Condom Program
EazeBio and UC Santa Cruz partner to advance instrument-free diagnostic platform
Orphan drug designation (ODD) by the USFDA for Desidustat, provides eligibility for a potential seven-year marketing exclusivity subject to the USFDA approval
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
